Effect of the GSK2245035 on the Allergen-induced Asthmatic Response

Condition:   Asthma
Interventions:   Drug: GSK2245035 Nasal Spray Solution;   Drug: Placebo Nasal Spray Solution
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified July 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *